Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces that Maxigesic IV is now available in Germany, the largest European pharmaceutical market, and Austria.
July 8, 2021
· 5 min read